Caris Life Sciences (CAI) FCF Margin (2024 - 2026)

Caris Life Sciences' FCF Margin history runs 3 years deep, the most recent figure standing at 15.28% for Q1 2026.

• In Q1 2026, FCF Margin rose 4117.0% year-over-year to 15.28%; the TTM figure through Mar 2026 stood at 16.26% (up 4803.0% YoY), while the FY2025 annual figure was 10.25%, up 7177.0% from the prior year.
• FCF Margin for Q1 2026 stood at 15.28%, down from 19.12% in the prior quarter.
• The five-year high for FCF Margin was 25.52% in Q3 2025, with the low at 64.22% in Q3 2024.
• The 3-year median for FCF Margin is 1.75% (2025), against an average of 9.25%.
• The sharpest annual moves came in 2025 and 2026: FCF Margin surged 8974 bps in 2025, then soared 4117 bps in 2026.
• Caris Life Sciences' FCF Margin stood at 36.34% in 2024, then jumped by 153 bps to 19.12% in 2025, then fell by 20 bps to 15.28% in 2026.
• Business Quant data shows CAI's FCF Margin at 15.28% in Q1 2026, 19.12% in Q4 2025, and 25.52% in Q3 2025.